At the CMP it is trading a Mcap/Sales of just 2.2x and I think that takes care of the potential down side. Mgmt seems to be not very prudent at execution. Equity dilutions, frequent closures and new subsidiaries etc are a definite drag on the stock. But valuations wise seems cheaper. What do other esteemed members think?
| Subscribe To Our Free Newsletter |
